Drew Weissman of the Perelman School of Medicine explained the science behind and advantages of mRNA-based vaccines. “With RNA, you only need the sequence of the protein of interest. Once you’ve got the sequence, you can make an RNA within days to weeks,” he said. “So, it’s very fast at responding to new pandemics, new emerging infections, and other potential diseases.”

May 7, 2021 ・ From “Here & Now with Robin Young and Jeremy Hobson,” WBUR-Radio (Boston)